7 research outputs found

    A cross sectional observational study of prevalence and risk factors of uncontrolled Asthma among adults in a tertiary care hospital

    No full text
    Introduction: Asthma is a chronic inflammatory disease of the airways causing episodes of airflow obstruction. This chronic inflammation increases airways hyper responsiveness (AHR) to stimulants. In general, Asthma has become an important public health problem. Asthma is not only a leading cause of hospitalization in children, but also an important chronic condition causing school absenteeism. There is also increase in hospital admissions and emergency department visits to a greater degree worldwide which has lead to changes in medical practice. Materials and Methods: A cross sectional observational study was conducted for a period of one year (January 2021 to December 2021) at the department of Respiratory Medicine, Sri Lakshmi Narayana Institute of Medical Sciences, Puducherry. All adults >18 years of age of both genders with a diagnosis of asthma according to GINA guidelines for a duration of at least one year. Other causes of obstructive airway disease like bronchiectasis, post TB Obstructive airway disease were excluded. Informed consent was obtained from all the participants. Results: A total of 220 subjects completed the questionnaire satisfactorily. The male: female ratio was 59:51 and mean age of subjects was 35.25±12.34 years with majority of them (59.1%) belonging to the 26-45-year age group.&nbsp

    A descriptive study of clinical profile of malignant pleural effusions in a tertiary care centre

    No full text
    Introduction: Pleural effusion (PE) refers to the excessive or abnormal accumulation of fluid in the pleural space. PE is commonly encountered medical problem and caused by a variety of underlying pathological conditions.1 They are classified broadly in to exudative and transudative effusion based on Light's criteria.2 Common causes of transudative effusions are congestive cardiac failure, cirrhosis, nephrotic syndrome, superior venacava obstruction, peritoneal dialysis, glomerulonephritis, myxoedema, pulmonary emboli and sarcoidosis whereas exudative PE is caused by neoplastic diseases, infections, pulmonary embolism, gastrointestinal diseases, collagen vascular diseases, drug induced, iatrogenic, hemothorax and chylothorax. Materials and Methods: A total of 178 consecutive cases ≥ 18 years having pleural effusion with proven underlying malignancy were included in the study. Detailed clinical history, general and systemic examination was done in all patients. A chest radiograph was done and the size of effusion was estimated in all cases. If the size of effusion was more than 2/3rd, it was considered large/ massive effusion. After preliminary examination and investigations, an informed consent was taken from all the patients regarding diagnostic thoracentesis. Further, every study participant was subjected to following investigations: pleural fluid cytology, pleural fluid LDH, pleural fluid proteins, S. proteins and S. LDH.&nbsp

    Treatment categories and regimens for TB patients in India.

    No full text
    <p>PTB = Pulmonary tuberculosis: EPTB = Extra pulmonary tuberculosis.</p><p>*In children, seriously ill sputum smear-negative PTB includes all forms of sputum smear-negative PTB other than primary complex. Seriously ill EPTB includes TB meningitis (TBM), disseminated TB, TB pericarditis, TB peritonitis and intestinal TB, bilateral extensive pleurisy, spinal TB with or without neurological complications, genitourinary TB, and bone and joint TB.</p><p>**Not seriously ill sputum smear-negative PTB includes primary complex. Not seriously ill EPTB includes lymph node TB and unilateral pleural effusion.</p><p>***Prefix indicates month and subscript indicates thrice weekly.</p><p>H = Isoniazid, R = Rifampicin, Z = Pyrazinamide, E = Ethambutol, S = Streptomycin, Km = Kanamycin, Levo = Levofloxacin, Eto = Ethionamide, Cs = Cycloserine,</p

    Type of Tuberculosis and treatment regimens of TB patients admitted to Government General and Chest Hospital, Hyderabad, India (2010).

    No full text
    <p>*RNTCP- Revised National Tuberculosis Control Programme.</p><p>**Regimen formulated based on the drug susceptibility of the individual patient to first and second line anti- TB treatment.</p><p>Cat-1 = Category 1, Cat-2 = category 2, Cat-3 = Category 3, Cat-4 = Category 4.</p
    corecore